libexin 100 mg tabletes
sanofi-aventis latvia, sia, latvija - prenoksdiazīna hidrohlorīds - tablete - 100 mg
no-spa forte 80 mg apvalkotās tabletes
sanofi-aventis latvia, sia, latvija - drotaverīna hidrohlorīds - apvalkotā tablete - 80 mg
cardace 10 mg tabletes
sanofi winthrop industrie, france - ramiprils - tablete - 10 mg
cardace 5 mg tabletes
sanofi winthrop industrie, france - ramiprils - tablete - 5 mg
cardace 2,5 mg tabletes
sanofi winthrop industrie, france - ramiprils - tablete - 2,5 mg
nexviadyme
sanofi b.v. - avalglucosidase alfa - glikogēna uzglabāšanas slimības ii tipa - citas gremošanas trakta un metabolisma produkti, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).
xenpozyme
sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - citas gremošanas trakta un metabolisma produkti, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.
depakine chrono 300 mg ilgstošās darbības tabletes
sanofi winthrop industrie, france - skābes valproicum, natrii valproas - ilgstošās darbības tablete - 300 mg
depakine chrono 500 mg ilgstošās darbības tabletes
sanofi winthrop industrie, france - natrii valproas, skābes valproicum - ilgstošās darbības tablete - 500 mg
depakine 57,64 mg/ml sīrups
sanofi winthrop industrie, france - nātrija valproāts - sīrups - 57,64 mg/ml